Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
2001.
Current Awareness.
Pharmacoepidemiology and Drug Safety,
Vol. 10,
Issue. 6,
p.
561.
Morton, R.E.
and
Murray-Leslie, C.F.
2001.
The role of botulinum toxin in the management of cerebral palsy.
Current Paediatrics,
Vol. 11,
Issue. 4,
p.
235.
Boyd, R. N.
and
Hays, R. M.
2001.
Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic review.
European Journal of Neurology,
Vol. 8,
Issue. s5,
p.
1.
Carrelet, P
Bollini, G
Mancini, J
and
Chabrol, B
2002.
Traitement de l'enfant infirme moteur cérébral par la toxine botulique A : mode d'action, place des injections dans la prise en charge.
Archives de Pédiatrie,
Vol. 9,
Issue. 9,
p.
928.
Carr, LJ
2002.
Management of cerebral palsy: the neurologist's view.
Hospital Medicine,
Vol. 63,
Issue. 10,
p.
584.
OʼBrien, Christopher F.
2002.
Treatment of Spasticity With Botulinum Toxin.
The Clinical Journal of Pain,
Vol. 18,
Issue. Supplement,
p.
S182.
Fragala, Maria A.
O???Neil, Margaret E.
Russo, Kara J.
and
Dumas, Helene M.
2002.
Impairment, Disability, and Satisfaction Outcomes After Lower-Extremity Botulinum Toxin A Injections for Children with Cerebral Palsy.
Pediatric Physical Therapy,
Vol. 14,
Issue. 3,
p.
132.
Schulte-Baukloh, H.
Michael, Th.
Stürzebecher, B.
and
Knispel, H.H.
2003.
Botulinum-A Toxin Detrusor Injection as a Novel Approach in the Treatment of Bladder Spasticity in Children with Neurogenic Bladder.
European Urology,
Vol. 44,
Issue. 1,
p.
139.
O’Neil, Margaret E.
Fragala, Maria A.
and
Dumas, Helene M.
2003.
Physical Therapy Intervention for Children with Cerebral Palsy Who Receive Botulinum Toxin A Injections.
Pediatric Physical Therapy,
Vol. 15,
Issue. 4,
p.
204.
Mackey, Anna
Walt, Sharon
and
Stott, N Susan
2003.
Botulinum Toxin Type A in Ambulant Children with Cerebral Palsy.
Physiotherapy,
Vol. 89,
Issue. 4,
p.
219.
&NA;
2003.
Botulinum A toxin is a valuable tool in managing spasticity associated with cerebral palsy in children.
Drugs & Therapy Perspectives,
Vol. 19,
Issue. 11,
p.
14.
Delgado, Mauricio R.
2003.
Botulinum Neurotoxin Type A.
Journal of the American Academy of Orthopaedic Surgeons,
Vol. 11,
Issue. 5,
p.
291.
Koman, L. Andrew
Paterson Smith, Beth
and
Balkrishnan, Rajesh
2003.
Spasticity Associated with Cerebral Palsy in Children.
Pediatric Drugs,
Vol. 5,
Issue. 1,
p.
11.
Bertrand, H
and
Forin, V
2003.
Toxine botulinique type A chez l’enfant : évaluation des indications à partir d’une revue de la littérature.
Annales de Réadaptation et de Médecine Physique,
Vol. 46,
Issue. 6,
p.
346.
Koman, L. Andrew
Paterson Smith, Beth
and
Balkrishnan, Rajesh
2003.
Spasticity Associated with Cerebral Palsy in Children.
Pediatric Drugs,
Vol. 5,
Issue. 1,
p.
11.
Gaebler-Spira, Deborah
and
Revivo, Gadi
2003.
The use of botulinum toxin in pediatric disorders.
Physical Medicine and Rehabilitation Clinics of North America,
Vol. 14,
Issue. 4,
p.
703.
Schwerin, Anette
Berweck, Steffen
Fietzek, Urban M.
and
Heinen, Florian
2004.
Botulinum toxin B treatment in children with spastic movement disorders: A pilot study.
Pediatric Neurology,
Vol. 31,
Issue. 2,
p.
109.
Markey, Andrew C
2004.
Dysport.
Dermatologic Clinics,
Vol. 22,
Issue. 2,
p.
213.
Koman, L Andrew
Smith, Beth Paterson
and
Shilt, Jeffrey S
2004.
Cerebral palsy.
The Lancet,
Vol. 363,
Issue. 9421,
p.
1619.
Hugeron, C
and
Denys, P
2004.
Actualités sur l’utilisation des toxines botuliques.
EMC - Podologie-Kinésithérapie,
Vol. 1,
Issue. 1,
p.
30.